BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 26, 2025
Home » Authors » Amanda Pedersen

Articles by Amanda Pedersen

Stryker wins FDA clearance for Trevo Pro Retriever

Aug. 14, 2012
By Amanda Pedersen
Stryker Neurovascular (Kalamazoo, Michigan) reported that its Trevo Pro Retriever has been granted 510(k) market clearance by the FDA. The Trevo Pro Retriever is the next generation in clot removal technology from Stryker, using its Stentriever technology for optimized clot integration and retrieval in patients experiencing acute ischemic stroke.
Read More

NewCo on the Block: Novasyte answers common device industry dilemma

Aug. 13, 2012
By Amanda Pedersen

Michigan study helps reduce unnecessary heart imaging

Aug. 10, 2012
By Amanda Pedersen
Appropriate use of imaging is nearly always under scrutiny as doctors and hospitals try to improve quality while containing costs, especially in cardiology where the potential consequences of incorrect diagnosis have led to overuse of coronary CT angiography (CCTA).
Read More

FDA approves Omnilink Elite stent for iliac artery disease

Aug. 8, 2012
By Amanda Pedersen
Abbott (Abbott Park, Illinois) reported FDA approval for its Omnilink Elite vascular balloon-expandable stent system for the treatment of iliac artery disease, a form of peripheral artery disease (PAD) that affects the lower extremities. Iliac artery disease can progress to where patients experience chronic pain and reduced ability to walk, potentially leading to permanent disability.
Read More

Bausch + Lomb, Technolas win FDA clearance for Victus

Aug. 7, 2012
By Amanda Pedersen
The FDA has cleared the first single-platform femtosecond laser designed for cataract and corneal surgery. Bausch + Lomb (B+L; Aliso Viejo, California) and Technolas Perfect Vision (TPV; Munich) today reported receiving 510(k) clearance to market the Victus femtosecond laser platform in the U.S. According to the companies, the Victus platform is the first femtosecond laser capable of supporting cataract and corneal procedures on a single platform. The versatile system is designed to provide greater precision compared to manual cataract surgery techniques, potentially enhancing patient experience, the companies noted.
Read More

FDA clears ingestible sensor from Proteus for smart drugs

Aug. 6, 2012
By Amanda Pedersen
Proteus Digital Health (Redwood City, California) has received FDA clearance for its ingestible sensor technology for marketing as a medical device.
Read More

Midwest health startups attract $491M in VC funds

Aug. 1, 2012
By Amanda Pedersen
Midwest healthcare startups are off to a strong start compared to this time last year in terms of raising funds from venture capital investors. The region's healthcare industry reported $491 million in total investments across 92 companies in the first half of 2012, according to the annual BioEnterprise Midwest Health Care Venture Investment report. The totals are the highest recorded for the region among the last five years both in dollars of financing and number of companies receiving investment, though still below the 2007 records, the organization reported.
Read More

Cleveland looking to rock the ortho device market

July 30, 2012
By Amanda Pedersen
Cleveland is known for many things: the Cleveland Clinic; the Rock and Roll Hall of Fame; and the city's de facto anthem, "Cleveland Rocks," a 1979 rock song by Ian Hunter. But one of Cleveland's lesser known strengths is its orthopedic device industry, which goes back to the days of a local startup company called AcroMed.
Read More

START shows correlation between brain scan and stroke outcomes

July 25, 2012
By Amanda Pedersen

Financings roundup: Histogenics raises $49M for NeoCart and VeriCart

July 25, 2012
By Amanda Pedersen
Previous 1 2 … 96 97 98 99 100 101 102 103 104 … 222 223 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 24, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 24, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Illustration of tau accumulating in a neuron cell.

    ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug

    BioWorld
    ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing